Wang Wenmeng, Li Dangdang, Sui Guangchao
College of Life Science, Northeast Forestry University, Harbin, China.
College of Life Science, Northeast Forestry University, Harbin, China; Department of Cancer Biology and Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
Crit Rev Oncog. 2017;22(1-2):1-11. doi: 10.1615/CritRevOncog.2017021314.
Yin Yang 1 (YY1) is a member of the GLI-Kruppel family of zinc finger proteins that plays vital roles in many biological processes, especially tumorigenesis. To date, ample evidence suggests a critical regulatory role of YY1 in tumor cell metastasis. The potential of YY1 as a valuable biomarker for cancer metastasis has been increasingly known. Here, we review the studies related to the expression, regulatory network, and clinical application of YY1 in cancer metastasis. We first summarize YY1 expression patterns in metastatic tumors. We then elaborate YY1-regulated mechanisms on five aspects, including epithelial-mesenchymal transition, cell migration and invasion, stemness, polyploidy, and genomic stability. Finally, we discuss the correlation between YY1 expression and clinical outcomes and therapeutic potential of YY1 in cancer treatment. Based on this review, we conclude that YY1 is a bona fide inducer of cancer metastasis and can serve as a clinical biomarker and therapeutic target for cancer treatment.
阴阳1(YY1)是锌指蛋白GLI-Kruppel家族的成员,在许多生物学过程中发挥着至关重要的作用,尤其是在肿瘤发生过程中。迄今为止,大量证据表明YY1在肿瘤细胞转移中起关键调节作用。YY1作为癌症转移有价值生物标志物的潜力已日益为人所知。在此,我们综述了与YY1在癌症转移中的表达、调控网络及临床应用相关的研究。我们首先总结了YY1在转移性肿瘤中的表达模式。然后从上皮-间质转化、细胞迁移与侵袭、干性、多倍体和基因组稳定性五个方面阐述YY1调控机制。最后,我们讨论了YY1表达与临床结局的相关性以及YY1在癌症治疗中的治疗潜力。基于本综述,我们得出结论,YY1是癌症转移的真正诱导因子,可作为癌症治疗的临床生物标志物和治疗靶点。